Pharmaphorum
Johnson Johnson’s ‘Swiss army knife’ drug Imaavy has shown efficacy in a pivotal trial involving patients with rare autoimmune disorder wAIHA.
Pharmaphorum
Johnson Johnson's 'Swiss army knife' drug Imaavy has shown efficacy in a pivotal trial involving patients with rare autoimmune disorder wAIHA.
Pharmaphorum
Johnson Johnson’s ‘Swiss army knife’ drug Imaavy has shown efficacy in a pivotal trial involving patients with rare autoimmune disorder wAIHA.